Literature DB >> 15577488

Modular porous metal augments for treatment of severe acetabular bone loss during revision hip arthroplasty.

Alexandre Nehme1, David G Lewallen, Arlen D Hanssen.   

Abstract

Modular acetabular augments were implanted in 16 patients (16 hips) for support of an uncemented hemispheric acetabular component during revision acetabular reconstruction. Based on the classification of Paprosky, acetabular bone defects were classified as 2A in one hip, 2B in three hips, 2C in one hip, 3A in five hips, and 3B in six hips. Preoperatively, the prosthetic femoral head centers were located at a mean horizontal distance of 18.6 mm (range, -3-46 mm), and a mean vertical distance of 27.6 mm (range, -16-52 mm) from the approximate femoral head center. Postoperatively, the prosthetic femoral head centers were located at a mean horizontal distance of 10.4 mm (range, 1-25 mm), and a mean vertical distance of 7.4 mm (range, -15-25 mm). At final followup, no implant had evidence of migration or loosening. At early clinical followup, this modular acetabular augment system seems helpful in acetabular reconstructions that cannot be treated with an uncemented hemispheric cup that would have required other forms of treatment such as structural allografts, acetabular cages, bilobed acetabular components, or custom acetabular components. Longer term followup is required to determine whether there are untoward effects of using a modular acetabular reconstructive system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577488     DOI: 10.1097/01.blo.0000150133.88271.80

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  54 in total

1.  Uncemented Porous Tantalum Acetabular Components: Early Follow-Up and Failures in 599 Revision Total Hip Arthroplasties.

Authors:  William J Long; Nicolas O Noiseux; Tad M Mabry; Arlen D Hanssen; David G Lewallen
Journal:  Iowa Orthop J       Date:  2015

2.  The Mark Coventry Award: Trabecular metal tibial components were durable and reliable in primary total knee arthroplasty: a randomized clinical trial.

Authors:  Luis Pulido; Matthew P Abdel; David G Lewallen; Michael J Stuart; Joaquin Sanchez-Sotelo; Arlen D Hanssen; Mark W Pagnano
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

3.  Acetabular cage survival and analysis of factors related to failure.

Authors:  Jonathan N Sembrano; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2008-02-26       Impact factor: 4.176

4.  Type III acetabular defect revision with bilobed components: five-year results.

Authors:  Joseph T Moskal; Michael E Higgins; Joseph Shen
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

5.  The first 50 years of total hip arthroplasty: lessons learned.

Authors:  William H Harris
Journal:  Clin Orthop Relat Res       Date:  2008-11-04       Impact factor: 4.176

Review 6.  Systematic review on outcomes of acetabular revisions with highly-porous metals.

Authors:  Samik Banerjee; Kimona Issa; Bhaveen H Kapadia; Robert Pivec; Harpal S Khanuja; Michael A Mont
Journal:  Int Orthop       Date:  2013-11-01       Impact factor: 3.075

7.  Tantalum components in difficult acetabular revisions.

Authors:  Paul F Lachiewicz; Elizabeth S Soileau
Journal:  Clin Orthop Relat Res       Date:  2009-07-07       Impact factor: 4.176

8.  A review of the treatment of pelvic discontinuity.

Authors:  M Villanueva; A Rios-Luna; J Pereiro De Lamo; H Fahandez-Saddi; M P G Böstrom
Journal:  HSS J       Date:  2008-07-15

Review 9.  [Acetabular defect reconstruction in revision surgery of the hip. Autologous, homologous or metal?].

Authors:  S Gravius; G Pagenstert; O Weber; N Kraska; H Röhrig; D C Wirtz
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

Review 10.  Cementless acetabular revision: past, present, and future. Revision total hip arthroplasty: the acetabular side using cementless implants.

Authors:  Luis Pulido; Sridhar R Rachala; Miguel E Cabanela
Journal:  Int Orthop       Date:  2011-01-14       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.